Abacus Wealth Partners LLC Invests $1.23 Million in Cigna Group $CI

Abacus Wealth Partners LLC bought a new position in shares of Cigna Group (NYSE:CI) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 4,464 shares of the health services provider’s stock, valued at approximately $1,229,000.

Other large investors have also made changes to their positions in the company. Beacon Financial Strategies CORP acquired a new position in shares of Cigna Group during the 4th quarter worth approximately $28,000. Collier Financial purchased a new position in shares of Cigna Group in the third quarter valued at approximately $34,000. Lodestone Wealth Management LLC purchased a new position in shares of Cigna Group in the fourth quarter valued at approximately $32,000. Activest Wealth Management lifted its position in shares of Cigna Group by 1,050.0% in the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock valued at $38,000 after acquiring an additional 126 shares in the last quarter. Finally, Founders Capital Management lifted its position in shares of Cigna Group by 53.0% in the third quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock valued at $44,000 after acquiring an additional 53 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Everett Neville sold 1,719 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the sale, the insider owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This represents a 23.26% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 205,904 shares of company stock valued at $60,277,068 in the last 90 days. Company insiders own 0.60% of the company’s stock.

Cigna Group Trading Down 3.3%

Shares of Cigna Group stock opened at $285.25 on Friday. The stock has a market cap of $75.46 billion, a P/E ratio of 12.09, a P/E/G ratio of 1.00 and a beta of 0.30. The stock’s 50 day simple moving average is $274.95 and its 200-day simple moving average is $275.97. Cigna Group has a 1-year low of $239.51 and a 1-year high of $338.89. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Analysts predict that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a $1.56 dividend. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is 26.45%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. Wells Fargo & Company raised their target price on Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research report on Friday, May 1st. Cantor Fitzgerald raised their target price on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. Truist Financial raised their target price on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Finally, Piper Sandler decreased their target price on Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and an average price target of $338.35.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.